| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1078155213498630 |
| P698 | PubMed publication ID | 23975555 |
| P2093 | author name string | Andrew Turner | |
| Nitin Vyas | |||
| Graham J Sewell | |||
| Dennis Yiannakis | |||
| P2860 | cites work | Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device | Q23919324 |
| Hazardous anticancer drugs in health care: environmental exposure assessment | Q23922583 | ||
| The Ames Salmonella/microsome mutagenicity assay | Q33927851 | ||
| Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel | Q34459756 | ||
| Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature | Q34564716 | ||
| Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. | Q35125608 | ||
| Cancer incidence in the United Kingdom: projections to the year 2030 | Q35623293 | ||
| Environmental and occupational causes of cancer: a call to act on what we know. | Q36955649 | ||
| Biomarkers of occupational exposure do anticancer agents: a minireview | Q37930750 | ||
| Monitoring of occupational exposure to cytostatic anticancer agents. | Q41090709 | ||
| Assessment of DNA damage in Japanese nurses handling antineoplastic drugs by the comet assay | Q42524891 | ||
| Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. | Q44111513 | ||
| Microbiological challenge of four protective devices for the reconstitution of cytotoxic agents | Q45043895 | ||
| Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device | Q45161788 | ||
| Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees | Q46734124 | ||
| Permeability of 13 different gloves to 13 cytotoxic agents under controlled dynamic conditions | Q46979822 | ||
| Mutagenicity in urine from nurses handling cytostatic agents | Q50202360 | ||
| Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs | Q50203443 | ||
| Mutagenicity in urine of nurses handling cytostatic drugs | Q50221388 | ||
| Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. | Q51135726 | ||
| Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective. | Q51294490 | ||
| Molecular biomonitoring of a population of nurses handling antineoplastic drugs. | Q53328219 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 278-287 | |
| P577 | publication date | 2013-08-22 | |
| P1433 | published in | Journal of Oncology Pharmacy Practice | Q6295681 |
| P1476 | title | Occupational exposure to anti-cancer drugs: A review of effects of new technology | |
| P478 | volume | 20 |
| Q95852113 | A Cost Saving and Waste Minimization Study About Handling of the Antineoplastic Agents |
| Q91307636 | A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics |
| Q48639965 | A strategy for formulating regulation on CSTDs |
| Q38247426 | Avoiding accidental exposure to intravenous cytotoxic drugs |
| Q35713385 | Carboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and FcεRI. |
| Q28397950 | Causes of Health Care Workers' Exposure to Antineoplastic Drugs: An Exploratory Study |
| Q91165477 | Challenges of Using Closed System Transfer Devices With Biological Drug Products: An Industry Perspective |
| Q92617892 | Environmental safety during the administration of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) |
| Q55020377 | Guidelines for safe handling of hazardous drugs: A systematic review. |
| Q92858446 | Latest advances in extracellular vesicles: from bench to bedside |
| Q58091326 | Performance testing protocol for closed-system transfer devices used during pharmacy compounding and administration of hazardous drugs |
| Q38521636 | Platinum hypersensitivity and desensitization |
| Q23921282 | Predictors of adherence to safe handling practices for antineoplastic drugs: a survey of hospital nurses |
| Q43324282 | Preventing the contamination of hospital personnel by cytotoxic agents: evaluation and training of the para-professional healthcare workers in oncology units |
| Q38608460 | Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries |
| Q49581570 | The need for national mandatory guidance on CSTDs |
Search more.